deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT03925935

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

A Phase 1, Open Label, Non-randomized, Multi-Center Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

Sponsor: Angiocrine Bioscience

Conditions Hodgkin Lymphoma Non-hodgkin Lymphoma
Interventions AB-205
Updated 15 times since 2019 Last updated: Mar 1, 2022 Started: May 7, 2019 Primary completion: Nov 18, 2020 Completion: Nov 8, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Hodgkin Lymphoma and Non-hodgkin Lymphoma and is currently completed. Angiocrine Bioscience leads this study, which shows 15 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Apr 2020 · 4 months · monthly snapshot~Apr 2020 – ~Nov 2020 · 7 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Jun 2021 · 2 months · monthly snapshot~Jun 2021 – ~Jan 2022 · 7 months · monthly snapshot~Jan 2022 – ~Apr 2022 · 3 months · monthly snapshot~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jan 2022 — Apr 2022 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  5. Jun 2021 — Jan 2022 [monthly]

    Active Not Recruiting PHASE1

▶ Show 10 earlier versions

  1. Apr 2021 — Jun 2021 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  2. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE1

  3. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  4. Apr 2020 — Nov 2020 [monthly]

    Recruiting PHASE1

  5. Dec 2019 — Apr 2020 [monthly]

    Recruiting PHASE1

  6. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE1

  7. Sep 2019 — Nov 2019 [monthly]

    Recruiting PHASE1

  8. Jul 2019 — Sep 2019 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  9. Jun 2019 — Jul 2019 [monthly]

    Not Yet Recruiting PHASE1

  10. May 2019 — Jun 2019 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Angiocrine Bioscience
  • California Institute for Regenerative Medicine (CIRM)
Data source: Angiocrine Bioscience

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations